Latest filing published 15 Oct 2021 for SAB Biotherapeutics, Inc., €4,356.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -92.1%Entry US$104.70 · Close at T+365 US$8.22
- -91.3%Entry US$100.70 · Close at T+365 US$8.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ilan Katz: trading record in brief
Ilan Katz discloses dealings in SAB Biotherapeutics, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 14 January 2021 and the latest from 13 October 2021.
Every open-market trade on record is a purchase: 3 purchases worth €3.4M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The median purchase comes to €8,717. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 15 October 2021: an open-market purchase of €4,356, in SAB Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ilan Katz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ US$10.10533.3% of flowCommon StockSEC:0001493152-21-025510:0Canonical exit: 11 Jan 2022 (T+90)
- 1,000 shares@ US$10.0966.7% of flowCommon StockSEC:0001493152-21-024640:0Canonical exit: 30 Dec 2021 (T+90)
- 417,200 shares@ US$10.0099.6% of flowCommon StockSEC:0001493152-21-001029:0Canonical exit: 14 Apr 2021 (T+90)
3 of 3 declarations
